pocketful logo
Genesis IBRC India Ltd logo

Genesis IBRC India Ltd

NSE: BSE: 514336

93.22

(4.92%)

Mon, 16 Mar 2026, 03:20 am

Genesis IBRC India Share Price Live Chart

1 Day

0 (0%)

No Result Found

Summary

  • Market Cap

    131.95

  • Net Profit

    3.50

  • P/B

    0

  • Sector P/E

    73.63

  • P/E

    0

  • EV/EBITDA

    0

  • Debt/Equity (Industry)

    0.58

  • Interest Cover (Industry)

    3.52

  • ROCE (Industry)

    5.50

  • RONW (Industry)

    4.72

  • ROE

    0

  • ROCE

    0

  • Debt/Equity

    0.15

  • EPS (TTM)

    0

  • Dividend Yield

    0

  • Book Value

    6.42

  • Interest Cover

    3.33

Analysis

all

thumbs up icon

Pros

  • Genesis IBRC India is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Genesis IBRC India has no debt, it does not need to be covered by operating cash flow.
  • Genesis IBRC India has no debt, it does not need to be covered by short term assets.
  • Genesis IBRC India has no long term commitments.
  • Genesis IBRC India currently has no debt however we can't compare to 5 years ago as we have no data for that period.
thumbs up icon

Cons

  • Unable to evaluate Genesis IBRC India's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Genesis IBRC India's dividend against the top 25% market benchmark as the company has not reported any payouts.
  • Genesis IBRC India has less than a year of cash runway if free cash flow continues to grow at historical rates of 14.9% each year.
  • Genesis IBRC India has less than a year of cash runway based on current free cash flow.
  • The average tenure for the Genesis IBRC India board of directors is less than 3 years, this suggests a new board.

Read More

Financials

No Result Found

Read More

Ratios

No Result Found

Read More

Shareholding

ShareholdersDEC 2025SEPT 2025JUN 2025MAR 2025DEC 2024
Promoters11.3311.3311.3311.3311.33
FII00000
DII00000
Public88.6788.6788.6788.6788.67
Government00000

Read More

Technical Analysis

RSI

70.29

MACD

3.89

50 DMA

81.48

200 DMA

68.40

Support and Resistance

TypeR3R2R1PPS1S2S3
Classic168.77124.2099.8279.6355.2535.06-
Fibonacci124.20107.1796.6579.6362.6052.0835.06
Camarilla87.7183.6279.5479.6371.3667.2863.19

Pivots Level: Classic

R3

+89.14

168.77

R2

+44.57

124.20

R1

+20.20

99.82

79.63
79.63
Pivot Point
LTP: 101.50

S1

-24.37

55.25

S2

-44.57

35.06

S3

-79.63

-

Moving Average

SMAEMA

Period

Value

  • 10-EMA

    89.05

  • 20-EMA

    84.46

  • 30-EMA

    83.70

  • 50-EMA

    85.69

  • 100-EMA

    86.08

  • 200-EMA

    72.77

Read More

Corporate Actions

Announcement DatePurposeActionEx Date
14 Feb 2026board-meetingsQuarterly Results
14 Nov 2025board-meetingsQuarterly Results, Half Yearly Results
29 Aug 2025agm
06 Sept 2024agm
05 Sept 2023agm
03 Sept 2022agm
31 Aug 2021agm

Read More

Peer Comparison

No Result Found

Genesis IBRC India Ltd logo

Genesis IBRC India Ltd

Aster DM Healthcare Ltd logo

Aster DM Healthcare Ltd

Narayana Hrudayalaya Ltd logo

Narayana Hrudayalaya Ltd

Max Healthcare Institute Ltd logo

Max Healthcare Institute Ltd

Fortis Healthcare Ltd logo

Fortis Healthcare Ltd

Apollo Hospitals Enterprise Ltd logo

Apollo Hospitals Enterprise Ltd

Read More

Genesis IBRC India Ltd About

Genesis IBRC India is engaged in the business of Biotechnology .

Industry

Miscellaneous

Founded

1992

Headquarters

CEO

Balakrishna Koppula

Employees

Contact

Website icon

Website

http://www.genesisibrc.com

Email icon

Email

cs@genesisibrc.com

Phone icon

Phone

Location icon

Location

Sy Nos 241/2 & 389/2 Dwaraka, Denduluru Village & Mandal, West Godavari, Andhra Pradesh, 534432

Read More

Genesis IBRC India Ltd Company History

YearHistory
1992
  • The Company was incorporated at Hyderabad, Andhra Pradesh on October 23, 1992
  • The Company obtained certificate of commencement of Business on November 17, 1992
2011
  • Mr. Y. Suryanarayan, Managing Director, was appointed as Compliance Officer of the Company on September 01, 2011.
2014
  • The company changed its name from Fine Plast Polymers Limited to SSK Lifestyles Limited
  • R V Radhakrishna was appointed as Company Secretary and Compliance Officer of the Company with effect from September 01, 2014.
2015
  • The Registered Office of the Company was shifted to 307, Nirmal Towers-200, Dwarakapuri Colony, Punjagutta, Hyderabad - 500082, Telangana.
2018
  • The company name was changed to Genesis IBRC India Ltd. from SSK Lifestyles Ltd.
  • Genesis I.B.R.C. Private Limited, a subsidiary of SSK Lifestyles, acquired Genesis Biosciences IBKC for Rs 58 lakh.

Read More

Deals

Client NameOrder SideQTYAvg PriceDate
AMARENDRA BUSSABuy12280004.128 Jun 2017
NAGA VENKATA TIRUMALA SRAVANI POTHURISell12280004.128 Jun 2017
NAGA KANAKA DURGA PRASAD CHALAVADIBuy6280004.1214 Jun 2017
SREEVANI VANKADARASell6280004.1214 Jun 2017
VENKATA RAJESH ANNAMBuy2250004.1607 Jun 2017
KALYAN SRINIVAS ABuy3220004.1607 Jun 2017
CHANDRA MOHAN SUBHASH ANNAMBuy2250004.1607 Jun 2017
SREEVANI VANKADARASell7720004.1607 Jun 2017

Read More

Genesis IBRC India Ltd News

Genesis IBRC Gets BSE Nod for ₹40.25 Cr Share Issue

Genesis IBRC India Limited received in-principle approval from BSE for preferential issue of 4.02 crore equity shares worth ₹40.25 crore to promoters and non-promoters at par value of ₹10 each.

13 Mar 2026

companies

Genesis IBRC Approves Name Change to CCME Global

Genesis IBRC India Limited shareholders approved company name change to CCME Global Limited, business expansion into FMCG sector, and key board appointments through postal ballot concluded March 5, 2026.

06 Mar 2026

stocks

Genesis IBRC India Reports Q3FY26 Loss

Genesis IBRC India Limited announced Q3FY26 results with net loss of ₹3.18 lakhs compared to ₹2.65 lakhs loss in Q3FY25. Nine-month loss widened to ₹21.46 lakhs.

14 Feb 2026

co actions results

Genesis IBRC Approves INR 40.25 Crore Preferential Issue

Genesis IBRC India Limited's board approved preferential allotment of 4.03 crore equity shares worth INR 40.25 crore at INR 10 per share to 11 investors including promoters and non-promoters.

28 Jan 2026

co actions results

Genesis IBRC: V Varalakshmi Transfers 64.33L Shares

V Varalakshmi disclosed transfer of 64.33 lakh equity shares of Genesis IBRC India Limited through inter-se gift transfer, reducing her stake from 61.58% to 12.09% on January 19, 2026.

21 Jan 2026

co actions results

Read More

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

pocketful logo

2022-25 Pocketful. All rights reserved, Built with in India

Version -5.76

app image 1app image 2

Explore

Calculatorsfooter arrow down icon
Popular Calculatorsfooter arrow down icon
Group Stocksfooter arrow down icon

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800